The Central Drugs Standard Control Organization, which regulates the sale and distribution drugs in India, has reportedly found popular medication like Combiflam, a pain reliever, and D Cold Total, a cold medicine, to be substandard.
Comiflam is manufactured by Sanofi India while D Cold Total is made by Reckitt Benckiser Healthcare India.
Along with these drugs, the CDSCO issued an alert for 55 other drugs, all of which failed different tests in March 2017, the Express reported.
ACTION PLAN BY SANOFI
Sanofi has said it will take “appropriate action” once it receives official notice from the drug regulator.
A company spokesperson told the Indian Express, “Certain batches of Combiflam manufactured in 2015 were deemed substandard because the tablets showed a delay in the disintegration time. Essentially, there are several pharmaceutical parameters that are routinely assessed, one of which is to check the breakdown of a tablet in the human body. The batch identified by the CDSCO in March 2017 was also manufactured in 2015.”